Katja Beesdo-Baum

Katja Beesdo-Baum

Auto-generated profile, based on publicly available information

Katja Beesdo-Baum

Behavioral Epidemiology, Institute of Clinical Psychology and Psychotherapy, Technische Universitat Dresden, Dresden, Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
CVCatharina Voss
Catharina Voss
TOTheresa M. Ollmann
Theresa M. Ollmann
MMMarcel Miché
Marcel Miché
JVJohn Venz
John Venz
JHJana Hoyer
Jana Hoyer
KBKatja Beesdo-Baum
Katja Beesdo-Baum
Adolescence and young adulthood are critical times for the onset of suicidal behavior.1-6 Prevalence estimates vary widely across different countries and studies.1,3 For adolescents and young adults, lifetime prevalence estimates range from 12.1% to 37.9% for suicidal ideation, 3.0% to 20.3% for plan, and 1.5% to 12.1% for attempt.1,4,7-10

26 September 2020 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
PDF file
CVCatharina Voss
Catharina Voss
JHJana Hoyer
Jana Hoyer
JVJohn Venz
John Venz
LPLars Pieper
Lars Pieper
KBKatja Beesdo‐Baum
Katja Beesdo‐Baum
Objective: Non‐suicidal self‐injury (NSSI) comprising thoughts and behaviors is common and often co‐occurring with suicidal behavior like ideation, plan, and attempt. As limited data are available for adolescents and young adults, this study aims to present prevalence estimates for lifetime NSSI, its co‐occurrence with suicidal behavior, conditional probabilities and their association with socio‐demographic characteristics, severity characteristics of suicidal behavior, and health service utilization.Method: The epidemiological Behavior and Mind Health (BeMIND) study assessed in 2015/16 a random‐community sample of N = 1180 aged 14–21 years from Dresden, Germany, regarding lifetime NSSI via self‐administered questionnaire and suicidal behaviors via standardized interview.Results: Any lifetime NSSI was reported by 19.3% (thoughts: 18.0%, behaviors: 13.6%) of the sample with higher prevalence in females (OR = 2.7, 95% CI 1.9–3.8, P < 0.001). Lifetime prevalence of co‐occurring NSSI and suicidal behavior was 7.7%. Females had a 3.3‐ to 8.8‐fold odds of co‐occurrence than males. Among those with any NSSI, 39.6% endorsed suicidal behavior, and 66.3% of those with any suicidal behavior reported NSSI. 42.3% of those with any NSSI reported to have used mental healthcare services at any time during their life with higher rates in those with co‐occurring suicidal behavior (62.3%).Conclusion: Non‐suicidal self‐injury and co‐occurring suicidal behavior is common in adolescents and young adults—especially females. The limited utilization of mental healthcare services underpins the need for improving recognition of NSSI and suicidal behavior as well as the accessibility of mental healthcare services during adolescence and emerging adulthood.

16 May 2015 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
KBKatja Beesdo-Baum
Katja Beesdo-Baum
SKSusanne Knappe
Susanne Knappe
EAEva Asselmann
Eva Asselmann
PZPetra Zimmermann
Petra Zimmermann
TBTanja Brückl
Tanja Brückl
HWHans-Ulrich Wittchen
Hans-Ulrich Wittchen

27 October 2017 in Deutsches Ärzteblatt international
Verified
Journal Article
Closed access
STSebastian Trautman
Sebastian Trautman
KBKatja Beesdo-Baum
Katja Beesdo-Baum
Depression is one of the most commonly occurring mental disorders (1) and is associated with considerable individual and social costs (2, 3). Early detection and effective treatment of depression are thus of major importance. Quality-assured...

10 April 2015 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
UMUlrike E Maske
Ulrike E Maske
MBMarkus A Busch
Markus A Busch
FJFrank Jacobi
Frank Jacobi
KBKatja Beesdo-Baum
Katja Beesdo-Baum
ISIngeburg Seiffert
Ingeburg Seiffert
UHUlfert Hapke
Ulfert Hapke
Prevalence estimates for depression vary considerably by the type of assessment instrument, and there is limited information on their overlap in population-based samples. Our aim was to compare the Patient Health Questionnaire-9 (PHQ-9) with the Composite International Diagnostic Interview (CIDI) as measures for current major depressive syndrome (MDS) in a large population-based sample. Data derived from the mental health module of the nationwide cross-sectional German Health Interview and Examination Survey for Adults (DEGS1-MH) (n = 4483; age 18–79 years). MDS in the past two weeks was assessed (a) using the PHQ-9 diagnostic algorithm (PHQ-MDS) and (b) based on CIDI information about the latest symptom occurrence (recency) (CIDI-MDS). Prevalences, overall concordance and percentages of overlap of both MDS measures were determined. Prevalences of affirmed PHQ-9 depression symptoms and the mean and median PHQ-9 sum scores were analyzed per measure. Prevalence of current MDS was 2.7% (95% CI: 2.0-3.6) for PHQ-MDS and 3.9% (95% CI: 3.1-5.0) for CIDI-MDS. The overall agreement between both measures was moderate (kappa: 0.43). Of all the participants, 1.5% (95% CI: 1.0-2.2) were classified as MDS cases by both measures, with 54.5% (95% CI: 42.7-65.9) of PHQ-MDS cases and 37.9% (95% CI: 27.8-49.1) of CIDI-MDS cases also being classified as MDS by the respective other MDS measure. However, 94.8% (95% CI: 93.6-95.8) of the participants were classified as non-MDS by both measures, with 97.5% (95% CI: 96.6-98.1) of non-PHQ-MDS and 98.7% (95% CI: 98.2-99.1) of non-CIDI-MDS being classified as non-MDS by the respective other MDS measure. The mean and median PHQ-9 sum score was higher in those with PHQ-MDS than in those with CIDI-MDS. Both measures have a high level of agreement for ruling out current MDS, but the overlap in their classification of cases is moderate. Our results indicate that they cannot be interpreted as equal measures of the same construct, suggesting limited comparability of their prevalence estimates. However, further exploration of algorithms and correlates and a proper labeling of measures in epidemiological studies are required.

18 November 2023 in Journal of Mood & Anxiety Disorders
Verified
Journal Article
Open access
SFSophia Fürtjes
Sophia Fürtjes
CVCatharina Voss
Catharina Voss
FRFrank Rückert
Frank Rückert
SPStephanie K.V. Peschel
Stephanie K.V. Peschel
HKHanna Kische
Hanna Kische
KBKatja Beesdo-Baum
Katja Beesdo-Baum
Self-efficacy (confidence in one’s abilities to execute behavior to reach ones goals) has been reported to reduce the impact of stress on symptoms of depression and anxiety. However, findings have been inconsistent regarding the two different conditions and the temporal resolution (individual situations [micro-level] vs. general disposition [macro-level], cross-sectional vs. longitudinal). By analyzing available data from an epidemiological cohort study, we explored the impact of self-efficacy, stress, and their interaction on symptoms of depression and anxiety in N = 1072 adolescents (age 14–21) from the general population. We conducted questionnaire assessments (macro-level) and ecological momentary assessment (EMA; micro-level). Multiple linear regressions and hierarchical linear modeling were applied to explore cross-sectional and longitudinal associations on both levels. On the micro-level, cross-sectional results indicate that self-efficacy lowers the impact of stress on depression, but not anxiety, during everyday life. Longitudinal effects were not found. On the macro-level, cross-sectional analyses revealed a buffering effect of self-efficacy against stress for anxiety, but not depression. Longitudinally, only direct effects could be observed for self-efficacy on anxiety and for stress on depression and anxiety. It appears that the adverse impact of stress on depression might be too strong to be buffered by self-efficacy in general, but only on a micro-level. The macro-level protective effect of self-efficacy regarding anxiety on the other hand might not be retrievable during everyday life. Results imply that therapy of depression might benefit from strategies to lower stress, whereas treatment of anxiety might focus on increasing self-efficacy to reduce avoidant behavior.